OptiNose Inc. (OPTN)
Industry: Drug Manufacturers – Specialty & Generic
Sector: Healthcare
OptiNose, Inc. is a specialty pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company's flagship product, XHANCE, is a therapeutic product that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. XHANCE utilizes OptiNose's proprietary exhalation delivery system (EDS). The company also offers Onzetra Xsail, a powder EDS device. OptiNose has a license agreement with Currax Pharmaceuticals LLC for the commercialization of Onzetra Xsail.
Support authors and subscribe to content
This is premium content. Subscribe to read the entire article.
Login if you have purchased
